Tech
A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research. The study is the first to show that clinical type 1 diabetes can be delayed by two or more years among people who are at high risk.
Baltimore (June 8, 2019) - Could changing what we eat lower the chances of developing type 2 diabetes? Studies presented at Nutrition 2019 will examine how consuming certain foods, vitamins and even the order in which we eat can affect blood sugar levels and risk of developing 2 diabetes.
The life of a type 1 diabetes patient - taking daily insulin shots or wearing an insulin pump, monitoring blood sugar, prioritizing healthful food choices and fitting in daily exercise - can be challenging at age 5 or 15, especially as holidays, field trips and sleepovers can disrupt diabetes care routines, creating challenges with compliance. This is why endocrinologists from Children's National Health System experimented with using health coaches over a 10-week period to help families navigate care for children with type 1 diabetes.
Tokyo, Japan - Researchers from Tokyo Metropolitan University have successfully found two distinct mechanisms by which foams can collapse, yielding insight into the prevention/acceleration of foam rupture in industrial materials e.g. foods, cosmetics, insulation, stored chemicals. When a bubble breaks, they found that a collapse event propagates via impact with the receding film and tiny scattered droplets breaking other bubbles. Identifying which mechanism is dominant in different foams may help tailor them to specific applications.
(Glasgow, 8 June, 2019) Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition are today presenting the results of a study that show higher levels of advanced glycation end products (AGEs), found in abundance in junk food, are associated with food allergy in children [1].
Doctors could soon get some help from an artificial intelligence tool when diagnosing brain aneurysms - bulges in blood vessels in the brain that can leak or burst open, potentially leading to stroke, brain damage or death.
The AI tool, developed by researchers at Stanford University and detailed in a paper published June 7 in JAMA Network Open, highlights areas of a brain scan that are likely to contain an aneurysm.
Researchers at the National Institute of Standards and Technology (NIST) and collaborators have demonstrated a compact frequency-comb apparatus that rapidly measures the entire infrared band of light to detect biological, chemical and physical properties of matter. Infrared light travels in waves longer than visible light and is most familiar as the radiation associated with heat.
Proof of sandwiched graphene-membrane superstructure opens up a membrane-specific drug delivery mode
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Tsinghua University (THU) proved a sandwiched superstructure for graphene oxide (GO) that transport inside cell membranes for the first time.
The discovery, published in Science Advances, opens up a membrane-specific drug delivery mode, which could significantly improve cytotoxicity effects over traditional drug carriers.
Veterans Affairs patients with diabetes have similar health outcomes regardless of whether their primary provider is a physician, nurse practitioner (NP), or physician assistant (PA), according to a Durham VA Health Care System study.
The results appear in the June 2019 edition of the Journal of the American Academy of Physician Assistants.
DALLAS (SMU) - Researchers at SMU's Center for Drug Discovery, Design and Delivery (CD4) have succeeded in lab testing the use of chemotherapy with a specific protein inhibitor so that the chemotherapeutic is better absorbed by drug-resistant cancer cells without harming healthy cells. The approach could pave the way for a more effective way to treat cancers that are resistant to treatment.
Although the knowledge we have about human cells and tissues has steadily increased over recent decades, many things remain unknown. For instance, cells exist in transient, dynamic states and understanding them is fundamental to decipher diseases and find cures. Classic techniques used in the lab to study cell types faced limitations and did not enable a finely detailed profile of cell function.
SAN ANTONIO - Small intestine bacterial overgrowth (SIBO) may be more prevalent among patients with restless legs syndrome (RLS), according to preliminary findings from a small, new study.
Results show that SIBO was found in all seven participants who have RLS. In contrast, the prevalence of SIBO in the general population is estimated to be no more than 15%.
UPTON, NY--Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory and the University of Arkansas have developed a highly efficient catalyst for extracting electrical energy from ethanol, an easy-to-store liquid fuel that can be generated from renewable resources. The catalyst, described in the Journal of the American Chemical Society, steers the electro-oxidation of ethanol down an ideal chemical pathway that releases the liquid fuel's full potential of stored energy.
Picture the future, where driving is a thing of the past. You can hop in your car or one from a ride-share, buckle up and tell the car where you want to go. During your ride, you can check your email and look up a few things online through your dashboard. Meanwhile, your whereabouts and other details are being tracked remotely by companies.
DURHAM, N.C. -- Scientists have discovered a small molecule drug that may stop cancer cells from becoming resistant to chemotherapy. Drug resistance is a major cause of cancer relapse and is responsible for as much as 90% of deaths related to the disease.
The new compound, which was tested in an animal model of melanoma, could make current chemotherapies more powerful. It works by thwarting cancer's ability to survive, evolve, and adapt to the DNA damage created by traditional chemotherapy drugs like cisplatin.